En savoir plus
This book primarily examines the clinical utilization of TMS (Transcranial Magnetic Stimulation) and tDCS (Transcranial Direct Current Stimulation) for various psychiatric conditions including major depressive disorder, bipolar disorder, schizophrenia, substance use disorders, obsessive-compulsive disorder, attention deficit hyperactivity disorder, autism spectrum disorders, anxiety disorders, post-traumatic stress disorder, sleep disorders, and neurocognitive disorders.
This book is tailored for students in clinical psychiatry, mental health professionals, and researchers specializing in psychiatric studies. It systematically presents the safety and efficacy of TMS and tDCS in the context of psychiatric disorders, while standardizing treatment protocols and operational techniques. The ultimate goal is to provide guidance for the clinical implementation of TMS and tDCS and to promote the standardization of these treatment modalities in the future.
Table des matières
Transcranial magnetic stimulation.- Transcranial direct current stimulation.- Depressive disorders.- Mood disorders.- Schizophrenia.- Substance use disorders.- Obsessive-compulsive disorder.- Attention deficit hyperactivity disorder.- Autism spectrum disorders.- Anxiety disorders.- Post-traumatic stress disorder.- Sleep disorders.
A propos de l'auteur
Editor Wei Zheng is an associate professor at the Department of Psychiatry, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. He completed resident psychiatrist training in the Affiliated Brain Hospital of Guangzhou Medical University, China, obtained PhD degree in Guangzhou Medical University. His research focuses on neuroregulatory techniques related research. Dr Zheng has authored or co-authored over 190 papers in international (SCI) journals. He is serving as one of the Editor-in-Chief of Alpha Psychiatry (IF=1.3). He was awarded the title of Top 2% Global Scientists in 2023 and 2024 years. His team has made some advances in antipsychotic-induced hyperproteinaemia and weight gain, ketamine and neuroregulatory techniques including TMS, tDCS, tACS and ECT for treatment-resistant depression.
Editor Yuping Ning is a professor at the Department of Psychiatry, the Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China. She is the director of the affiliated brain hospital of Guangzhou Medical University P.R.C. She is professor in neuropsychiatry and supervisor of PH.D students. She holds some positions such as member of Chinese Society of Psychiatry, Chairman of Guangdong Society of Psychiatry, member of standing committee of Guangdong Society of Neurology, etc. From 1986 to 1992, she educated in XiangYa Medical college and got MD degree there. From 1992 to 1997, she practiced psychiatry in Guangzhou Brain Hospital. From 1997 to 2003, she practiced and pursued her PHD in department of Neurology, Sun Yat-Sen medical university. Her research interests are in neurodegenerative diseases (AD and PD) and depression. As a visiting scholar, she performed genetic study in Parkinson disease in Juntendo University Japan. She has published 200 papers so far.
Résumé
This book primarily examines the clinical utilization of TMS (Transcranial Magnetic Stimulation) and tDCS (Transcranial Direct Current Stimulation) for various psychiatric conditions including major depressive disorder, bipolar disorder, schizophrenia, substance use disorders, obsessive-compulsive disorder, attention deficit hyperactivity disorder, autism spectrum disorders, anxiety disorders, post-traumatic stress disorder, sleep disorders, and neurocognitive disorders.
This book is tailored for students in clinical psychiatry, mental health professionals, and researchers specializing in psychiatric studies. It systematically presents the safety and efficacy of TMS and tDCS in the context of psychiatric disorders, while standardizing treatment protocols and operational techniques. The ultimate goal is to provide guidance for the clinical implementation of TMS and tDCS and to promote the standardization of these treatment modalities in the future.
